↓ Skip to main content

The role of Phosphodiesterase-1 and its natural product inhibitors in Alzheimer’s disease: A review

Overview of attention for article published in Frontiers in Pharmacology, December 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The role of Phosphodiesterase-1 and its natural product inhibitors in Alzheimer’s disease: A review
Published in
Frontiers in Pharmacology, December 2022
DOI 10.3389/fphar.2022.1070677
Pubmed ID
Authors

Nazir Ahmad, Kaisun Nesa Lesa, Ari Sudarmanto, Nanang Fakhrudin, Zullies Ikawati

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 9%
Student > Master 2 9%
Student > Ph. D. Student 2 9%
Lecturer 1 4%
Unspecified 1 4%
Other 1 4%
Unknown 14 61%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Unspecified 1 4%
Nursing and Health Professions 1 4%
Computer Science 1 4%
Other 1 4%
Unknown 14 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2023.
All research outputs
#2,998,865
of 23,530,272 outputs
Outputs from Frontiers in Pharmacology
#1,229
of 17,123 outputs
Outputs of similar age
#58,944
of 440,371 outputs
Outputs of similar age from Frontiers in Pharmacology
#25
of 999 outputs
Altmetric has tracked 23,530,272 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,123 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,371 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 999 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.